Literature DB >> 25832663

Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type III.

Nicolai Preisler1, Pascal Laforêt2, Karen Lindhardt Madsen2, Kira Philipsen Prahm2, Gitte Hedermann2, Christoffer Rasmus Vissing2, Henrik Galbo2, John Vissing2.   

Abstract

OBJECTIVE: Glycogen storage disease type IIIa (GSDIIIa) is classically regarded as a glycogenosis with fixed weakness, but we hypothesized that exercise intolerance in GSDIIIa is related to muscle energy failure and that oral fructose ingestion could improve exercise tolerance in this metabolic myopathy.
METHODS: We challenged metabolism with cycle-ergometer exercise and measured substrate turnover and oxidation rates using stable isotope methodology and indirect calorimetry in 3 patients and 6 age-matched controls on 1 day, and examined the effect of fructose ingestion on exercise tolerance in the patients on another day.
RESULTS: Total fatty acid oxidation rates during exercise were higher in patients than controls, 32.1 (SE 1.2) vs 20.7 (SE 0.5; range 15.8-29.3) μmol/kg/min (p = 0.048), and oxidation of carbohydrates was lower in patients, 1.0 (SE 5.4) vs 38.4 (SE 8.0; range 23.0-77.1) μmol/kg/min (p = 0.024). Fructose ingestion improved exercise tolerance in the patients.
CONCLUSION: Similar to patients with McArdle disease, in whom muscle glycogenolysis is also impaired, GSDIIIa is associated with a reduced skeletal muscle oxidation of carbohydrates and a compensatory increase in fatty acid oxidation, and fructose ingestion improves exercise tolerance. Our results indicate that GSDIIIa should not only be viewed as a glycogenosis with fixed skeletal muscle weakness, but should also be considered among the glycogenoses presenting with exercise-related dynamic symptoms caused by muscular energy deficiency. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that ingestion of fructose improves exercise tolerance in patients with GSDIIIa.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832663     DOI: 10.1212/WNL.0000000000001518

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

Review 2.  Glycogen metabolism in humans.

Authors:  María M Adeva-Andany; Manuel González-Lucán; Cristóbal Donapetry-García; Carlos Fernández-Fernández; Eva Ameneiros-Rodríguez
Journal:  BBA Clin       Date:  2016-02-27

3.  Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC).

Authors:  Renata S Scalco; Alejandro Lucia; Alfredo Santalla; Andrea Martinuzzi; Marinela Vavla; Gianluigi Reni; Antonio Toscano; Olimpia Musumeci; Nicol C Voermans; Carlyn V Kouwenberg; Pascal Laforêt; Beatriz San-Millán; Irene Vieitez; Gabriele Siciliano; Enrico Kühnle; Rebeca Trost; Sabrina Sacconi; Mads G Stemmerik; Hacer Durmus; Biruta Kierdaszuk; Andrew Wakelin; Antoni L Andreu; Tomàs Pinós; Ramon Marti; Ros Quinlivan; John Vissing
Journal:  Orphanet J Rare Dis       Date:  2020-11-24       Impact factor: 4.123

4.  Effects of acute nutritional ketosis during exercise in adults with glycogen storage disease type IIIa are phenotype-specific: An investigator-initiated, randomized, crossover study.

Authors:  Irene J Hoogeveen; Foekje de Boer; Willemijn F Boonstra; Caroline J van der Schaaf; Ulrike Steuerwald; Anita J Sibeijn-Kuiper; Riemer J K Vegter; Johannes H van der Hoeven; M Rebecca Heiner-Fokkema; Kieran C Clarke; Pete J Cox; Terry G J Derks; Jeroen A L Jeneson
Journal:  J Inherit Metab Dis       Date:  2020-09-07       Impact factor: 4.982

5.  Energy metabolism during exercise in patients with β-enolase deficiency (GSDXIII).

Authors:  Astrid Emilie Buch; Olimpia Musumeci; Ralph Wigley; Mads Peter Godtfeldt Stemmerik; Anne-Sofie Vibæk Eisum; Karen Lindhardt Madsen; Nicolai Preisler; David Hilton-Jones; Ros Quinlivan; Antonio Toscano; John Vissing
Journal:  JIMD Rep       Date:  2021-06-14

6.  Genetic analysis and clinical assessment of four patients with Glycogen Storage Disease Type IIIa in China.

Authors:  Yu Zhang; Mingming Xu; Xiaoxia Chen; Aijuan Yan; Guoyong Zhang; Zhenguo Liu; Wenjuan Qiu
Journal:  BMC Med Genet       Date:  2018-04-04       Impact factor: 2.103

7.  Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.

Authors:  Serena Pagliarani; Sabrina Lucchiari; Gianna Ulzi; Michela Ripolone; Raffaella Violano; Francesco Fortunato; Andreina Bordoni; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-08-01       Impact factor: 5.187

8.  Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study.

Authors:  Philip J Hennis; Elaine Murphy; Rick I Meijer; Robin H Lachmann; Radha Ramachandran; Claire Bordoli; Gurinder Rayat; David J Tomlinson
Journal:  Orphanet J Rare Dis       Date:  2022-01-31       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.